Skip to main content
. 2017 Mar 23;8(20):33014–33023. doi: 10.18632/oncotarget.16520

Table 2. Incidences and hazard ratios for breast cancer and breast cancer-associated factors.

Variable Event PY Rate# Crude HR (95% CI) Adjusted HR (95% CI)
Uterine leiomyoma
 No 706 577858 1.22 1.00 1.00
 Yes 243 147581 1.65 1.35 (1.16, 1.56)*** 1.31(1.13, 1.52)***
Age group
 20−39 196 265662 0.74 1.00 1.00
 40−44 333 209478 1.59 2.15(1.80, 2.56)*** 2.11(1.77, 2.52)***
 ≥ 45 420 250298 1.68 2.27(1.92, 2.69)*** 2.19(1.82, 2.63)***
Mammogram screening
 0 824 631905 1.30 1.00 1.00
 1 89 60489 1.47 1.09 (0.88, 1.36) -
 2 20 17930 1.12 0.82 (0.53, 1.28) -
 ≥ 3 16 15114 1.06 0.77 (0.47, 1.26) -
Comorbidity
 Hypertension
  No 826 651932 1.27 1.00 1.00
  Yes 123 73507 1.67 1.32 (1.09, 1.59)** 1.05(0.85, 1.29)
 Diabetes
  No 916 707931 1.29 1.00 1.00
  Yes 33 17507 1.88 1.48 (1.05, 2.10)* 1.26(0.87, 1.81)
Hyperlipidemia
  No 854 665936 1.28 1.00 1.00
  Yes 95 59503 1.60 1.25 (1.01, 1.54)* 0.93(0.74, 1.17)
 TUD
  No 947 724433 1.31 1.00 1.00
  Yes 2 1006 1.99 1.71(0.43, 6.85) -
 ARD
  No 940 720102 1.31 1.00 1.00
  Yes 9 5336 1.69 1.34(0.69, 2.58) -
 BBT
  No 849 693056 1.23 1.00 1.00
  Yes 100 32383 3.09 2.58 (2.10, 3.18)*** 2.39(1.94, 2.95)***
 MPD
  No 817 652027 1.25 1.00 1.00
  Yes 132 73411 1.80 1.43 (1.19, 1.72)*** 1.08(0.88, 1.32)
 Obesity
  No 938 716310 1.31 1.00 1.00
  Yes 11 9128 1.21 0.96 (0.53, 1.74) -
 Infertility
  No 939 708639 1.33 1.00 1.00
  Yes 10 16799 0.60 0.47 (0.25, 0.88)* 0.60(0.32, 1.12)
Medication
 Estrogen
  No 916 697353 1.31 1.00 1.00
  Yes 33 28086 1.17 0.84(0.60, 1.20) -
 Progesterone
  No 922 695991 1.32 1.00 1.00
  Yes 27 29448 0.92 0.66(0.45, 0.97)* 0.53(0.36, 0.77)**

ARD, alcohol-related diseases; BBT, benign breast tumor; CI, confidence interval; HR, hazard ratio; MPD, menopausal and postmenopausal disorders; PY, person-years; TUD, tobacco use disorders;

#Incidence rate per 1,000 person-years;

Multivariable analysis including age, comorbidities of hypertension, diabetes, hyperlipidemia, benign breast tumor, menopausal and postmenopausal disorders and infertility, and medication of progesterone;

*p < 0.05, **p < 0.01, ***p < 0.001.